Infex Therapeutics raises £4.3 million to advance drug-resistant infection pipeline

Infex Therapeutics announces it has secured £4.3 million in funding led by British venture capitalist Jon Moulton, with participation from the GM&C Life Sciences Fund (managed by Catapult Ventures) and existing high net worth investors. The funding will support the continued advancement of Infex’s p...